Posts in tag

medicines australia


CSO wholesalers have labelled the Grattan Institute’s latest report on PBS medicine pricing as “a simplistic response to a complex problem” National Pharmaceutical Services Association Chair and Sigma Pharmaceuticals CEO …

A widespread switch from prescription to OTC medicines is best for the healthcare system and consumers, says ASMI in its 2017 pre-budget submission The Australian Self-Medication Industry, which released its …

Pharma industry heavyweights have released their first reports detailing payments to healthcare professionals The reports give a rundown of each company’s payments to healthcare professionals for “provision of services” and …

Peak body representing the pharmaceutical industry welcomes new chief executive with lengthy experience in public service and environmental policy Medicines Australia today announced the appointment of Milton Catelin as the …

Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine suppliers since 1 April, say Medicines Australia, the Generic and Biosimilar Medicines Association, …

Medicines Australia CEO Tim James announced over the weekend his resignation effective January 2016 from the leadership role of the pharmaceutical sector peak body. Medicines Australia Interim Chairman Wes Cook …

A new report has found that investing in new medicines pays for itself by reducing other public health expenditure. The modeling, published in The impact of pharmaceutical innovation on premature …

Dr Martin Cross, chairman of Medicines Australia, will retire from the Board upon the conclusion of the current Board term on 20 October 2015. Dr Cross was appointed to the …

The High Court decision to disallow patenting of isolated genetic materials is a worry for the innovative medicines sector, says Medicines Australia. “It is essential that Australia maintains strong and …

The outcomes of the negotiations for the Trans-Pacific Partnership agreed to in Atlanta overnight are a disappointing outcome and a missed opportunity to stimulate and grow the Australian biopharmaceutical industry, …

The Guild and other health professional and consumer organisations have voiced their support for the transparency changes in the new Medicines Australia 18th Code of Conduct, which has come into …

The 2015 PricewaterhouseCoopers survey of the Australian medicines industry provides an important and timely insight into the challenges and opportunities confronting the Australian innovative medicines industry, says Medicines Australia. The …